reports
Lonza Implements its Simplified and Streamlined Operating Model
Lonza Group AG / Key word(s): Miscellaneous Lonza Implements its Simplified and Streamlined Operating Model 01.04.2025 / 14:00 CET/CEST Lonza’s new simplified and streamlined operating model is designed to support its One Lonza vision and strategy Previous divisional structure is now replaced with three newly formed CDMO Business Platforms: Integrated Biologics, Advanced Synthesis, and Specialized Modalities The model comes into effect today, and is reflected on the updated website Basel, Switzerland, 1 April 2025 – Lonza has announced that its new simplified and streamlined o...
Lonza Completes its Share Buyback Program
Lonza Group AG / Key word(s): Share Buyback Lonza Completes its Share Buyback Program 01.04.2025 / 07:00 CET/CEST Basel, Switzerland, 1 April 2025 – Lonza today announced the successful completion of its share buyback program of up to CHF 2 billion which was launched on 3 April 2023. Through the program, Lonza repurchased 4,239,731 of its shares on a second trading line on the SIX Swiss Exchange for an average purchase price of CHF 471.7279 per share.The Board of Directors intends to use the capital band to cancel the shares repurchased under the share buyback program. More informa...
Résolutions de l’Assemblée générale annuelle mixte des actionnaires de...
Sartorius Stedim Biotech SA / Mot-clé(s) : Assemblée générale Résolutions de l’Assemblée générale annuelle mixte des actionnaires de Sartorius Stedim Biotech S.A. 25-Mars-2025 / 15:35 CET/CEST Aubagne, le 25 mars 2025 Résolutions de l’Assemblée générale annuelle mixte des actionnaires de Sartorius Stedim Biotech S.A.Lors de l'Assemblée générale annuelle mixte de Sartorius Stedim Biotech S.A. qui s'est tenue aujourd'hui, les actionnaires à une large majorité ont donné décharge à tous les administrateurs.Les actionnaires ont élu Cécile Dussart et Christopher Nowers en tant que nouve...
Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius ...
Sartorius Stedim Biotech SA / Key word(s): AGM/EGM Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A. 25-March-2025 / 15:35 CET/CEST Aubagne, France | March 25, 2025 Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.At today’s combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A., shareholders granted discharge to all Directors by a large majority.The shareholders elected Cécile Dussart and Christopher Nowers as new Board Members. To ensure staggering of office terms, both were appointed...
Lonza Group AG: 1 director
A director at Lonza Group AG bought 270 shares at 546.082CHF and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
Sartorius Stedim Biotech releases Universal Registration Document 2024
Sartorius Stedim Biotech SA / Key word(s): Annual Results Sartorius Stedim Biotech releases Universal Registration Document 2024 17-Feb-2025 / 10:02 CET/CEST Aubagne, France | February 17, 2025 Sartorius Stedim Biotech releases Universal Registration Document 2024Sartorius Stedim Biotech, a leading partner of the biopharma industry, today released its Universal Registration Document 2024 including the Annual Financial Report. The document is available at the following link: Financial calendar March 25, 2025 Annual Shareholders’ Meeting April 16, 2025 ...
Sartorius Stedim Biotech publie son Document d’Enregistrement Universe...
Sartorius Stedim Biotech SA / Mot-clé(s) : Résultat annuel Sartorius Stedim Biotech publie son Document d’Enregistrement Universel 2024 17-Fév-2025 / 10:02 CET/CEST Aubagne, le 17 février 2025 Sartorius Stedim Biotech publie son Document d’Enregistrement Universel 2024Sartorius Stedim Biotech, partenaire de premier plan de l’industrie biopharmaceutique, a publié aujourd’hui son Document d‘Enregistrement Universel 2024 incluant le rapport financier annuel. Le document est disponible à l’adresse suivante : Agenda financier 25 mars 2025 Assemblée générale annuelle de...
Le Conseil d’administration de Sartorius Stedim Biotech décide de prop...
Sartorius Stedim Biotech SA / Mot-clé(s) : Dividende Le Conseil d’administration de Sartorius Stedim Biotech décide de proposer un dividende de 0,69 euro par action à l’Assemblée générale annuelle des actionnaires 07-Fév-2025 / 15:57 CET/CEST Aubagne, le 7 février 2025 Le Conseil d’administration de Sartorius Stedim Biotech décide de proposer un dividende de 0,69 euro par action à l’Assemblée générale annuelle des actionnaires Cécile Dussart et Christopher Nowers candidats à l'élection au Conseil d'administration lors de la prochaine Assemblée générale des actionnaires Le Consei...
Board of Directors of Sartorius Stedim Biotech resolves to propose div...
Sartorius Stedim Biotech SA / Key word(s): Dividend Board of Directors of Sartorius Stedim Biotech resolves to propose dividend of 0.69 euros per share to Annual Shareholders’ Meeting 07-Feb-2025 / 15:57 CET/CEST Aubagne, February 7, 2025Board of Directors of Sartorius Stedim Biotech resolves to propose dividend of 0.69 euros per share to Annual Shareholders’ Meeting Cécile Dussart and Christopher Nowers nominated for election to the Board of Directors at the upcoming Shareholders’ Meeting The Board of Directors of Sartorius Stedim Biotech S.A. resolved at its meeting to submi...
- Thomas J. Schiessle
Vorsichtige Guidance FY 25 sieht moderates, profitables Wachstum – lan...
Der scheidende CEO plant die 1. Guidance FY 25 nur qualitativ und in „bewusst vorsichtigem Grundton“ (Konkretisierung am 16.04.25). Die Visibilität „werde besser“. Lagerabbau und Investitionszurückhaltung seien in Q4/24 überwunden, ein stabiles positives Momentum sei aber noch nicht erkennbar.
- Thomas J. Schiessle
Cautious FY 25 guidance sees moderate, profitable growth – slow start ...
The outgoing CEO plans to give only a qualitative outlook for the first time in FY 25 and in a “deliberately cautious tone” (more details on April 16, 2025). Visibility “will improve”. Inventory reductions and investment restraint were overcome in Q4/24, but a stable positive momentum is not yet visible.
- Konrad Zomer
- Marc Lavaud
- Youssef Besbes
BMW BAYERISCHE MOTOREN WERKE AKTIENGESELLSCHAFT
REL RELX PLC
BT.A BT GROUP PLC
KNEBV KONE OYJ CLASS B
RNO RENAULT SA
KPN ROYAL KPN NV
PUM PUMA SE
VOLV B VOLVO AB CLASS B
EO FAURECIA SA
DAI DAIMLER AG
ABB ABB LTD.
LONN LONZA GROUP AG
POM PLASTIC OMNIUM SE
GLE SOCIETE GENERALE S.A. CLASS A
NOKIA NOKIA OYJ
TYRES NOKIAN RENKAAT OYJ
WKL WOLTERS KLUWER NV
FR VALEO SE
SAN SANOFI
VOW3 VOLKSWAGEN AG PREF
SY1 SYMRISE AG
HM B H&M HENNES & MAURITZ AB CLASS B
CIE CIE AUTOMOTIVE S.A.
RACE FERRARI NV
ASML ASML HOLDING NV
PIRC PIRELLI & C. S.P.A.
VOD VODAFONE GROUP PLC
STM STMICROELECTRONICS NV
GEST GESTAMP AUTOMOCION S.A.
CPR DAVIDE CAMPARI-MILANO N.V.
ERF EUROFINS SCIENTIFIC SOCIETE EUROPEENNE
AML ASTON MARTIN LAGONDA GLOBAL HOLDINGS
STLA STELLANTIS N.V.
SHEL SHELL PLC
ML COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN
P911 DR. ING. H.C. F. PORSCHE AKTIENGESELLSCHAFT
ALIV SDB AUTOLIV INC.
BRE BREMBO S.P.A.
- Konrad Zomer
- Marc Lavaud
- Youssef Besbes
BMW BAYERISCHE MOTOREN WERKE AKTIENGESELLSCHAFT
REL RELX PLC
TKA THYSSENKRUPP AG
BT.A BT GROUP PLC
MT ARCELORMITTAL SA
BEKB BEKAERT SA
AAL ANGLO AMERICAN PLC
KNEBV KONE OYJ CLASS B
RNO RENAULT SA
APAML APERAM SA
KPN ROYAL KPN NV
PUM PUMA SE
ROG ROCHE HOLDING LTD
VOLV B VOLVO AB CLASS B
OUT1V OUTOKUMPU OYJ
EO FAURECIA SA
SSAB A SSAB AB CLASS A
DAI DAIMLER AG
ABB ABB LTD.
LONN LONZA GROUP AG
POM PLASTIC OMNIUM SE
GLE SOCIETE GENERALE S.A. CLASS A
SZG SALZGITTER AG
NOKIA NOKIA OYJ
TYRES NOKIAN RENKAAT OYJ
WKL WOLTERS KLUWER NV
VOE VOESTALPINE AG
ACX ACERINOX SA
FR VALEO SE
SAN SANOFI
VOW3 VOLKSWAGEN AG PREF
ERA ERAMET SA
SY1 SYMRISE AG
NDA AURUBIS AG
HM B H&M HENNES & MAURITZ AB CLASS B
CIE CIE AUTOMOTIVE S.A.
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
RACE FERRARI NV
RIO RIO TINTO PLC
BHP BHP GROUP LTD
ASML ASML HOLDING NV
PIRC PIRELLI & C. S.P.A.
VOD VODAFONE GROUP PLC
STM STMICROELECTRONICS NV
GEST GESTAMP AUTOMOCION S.A.
CPR DAVIDE CAMPARI-MILANO N.V.
ERF EUROFINS SCIENTIFIC SOCIETE EUROPEENNE
AML ASTON MARTIN LAGONDA GLOBAL HOLDINGS
STLA STELLANTIS N.V.
SHEL SHELL PLC
ML COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN
P911 DR. ING. H.C. F. PORSCHE AKTIENGESELLSCHAFT
ALIV SDB AUTOLIV INC.
BRE BREMBO S.P.A.
- Oliver Metzger
- Stephan Wulf
- Dominic Rose
- Naresh Chouhan
Sartorius Stedim - Upgrade to HOLD (HOLD [SELL], TP EUR230 [120], 9pgs...
We upgrade Stedim to Hold after a strong Q4 order book and signs of improvement across the bioprocessing industry. Whilst the Stedim valuation seems very stretched to us, we feel comfortable sales can grow HSD this year with a 2% FX tailwind, improving order book & signs that many customers are now back to normal ordering patterns. Our proprietary biologic demand model shows that demand should grow 9% this year but is slowing over the coming years & our yield analysis shows that improving yields...
- Julian Dobrovolschi
- Julian Dobrovolschi
- Oliver Metzger
- Stephan Wulf
- Benoit Valleaux
- Steven Gould
- Youssef Besbes
IFX INFINEON TECHNOLOGIES AG
GET GETLINK SE
TKA THYSSENKRUPP AG
MT ARCELORMITTAL SA
BNP BNP PARIBAS SA CLASS A
APAML APERAM SA
OUT1V OUTOKUMPU OYJ
SSAB A SSAB AB CLASS A
DAI DAIMLER AG
SRT3 SARTORIUS AG PREF
SZG SALZGITTER AG
KCO KLOECKNER & CO SE
JCQ JACQUET METALS SA
VOE VOESTALPINE AG
ELG ELMOS SEMICONDUCTOR SE
ACX ACERINOX SA
TPE PVA TEPLA AG
DTE DEUTSCHE TELEKOM AG
SOI SOITEC SA
ASM ASM INTERNATIONAL N.V.
AIXA AIXTRON SE
PFV PFEIFFER VACUUM TECHNOLOGY AG
HM B H&M HENNES & MAURITZ AB CLASS B
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
WAF SILTRONIC AG
DIM SARTORIUS STEDIM BIOTECH SA
MELE MELEXIS NV
SMHN SUESS MICROTEC AG
VACN VAT GROUP AG
SAP SAP SE
XFAB X-FAB SILICON FOUNDRIES SE
ASML ASML HOLDING NV
STM STMICROELECTRONICS NV
BESI BE SEMICONDUCTOR INDUSTRIES N.V.
ALKAL KALRAY SA
JEN JENOPTIK AG
ENR SIEMENS ENERGY AG
ARM ARM HOLDINGS PLC
AMS AMS-OSRAM AG
- Benoit Valleaux
- Steven Gould
- Youssef Besbes
IFX INFINEON TECHNOLOGIES AG
GET GETLINK SE
TKA THYSSENKRUPP AG
MT ARCELORMITTAL SA
BNP BNP PARIBAS SA CLASS A
APAML APERAM SA
OUT1V OUTOKUMPU OYJ
SSAB A SSAB AB CLASS A
DAI DAIMLER AG
SRT3 SARTORIUS AG PREF
SZG SALZGITTER AG
KCO KLOECKNER & CO SE
JCQ JACQUET METALS SA
VOE VOESTALPINE AG
ELG ELMOS SEMICONDUCTOR SE
ACX ACERINOX SA
TPE PVA TEPLA AG
DTE DEUTSCHE TELEKOM AG
SOI SOITEC SA
ASM ASM INTERNATIONAL N.V.
AIXA AIXTRON SE
PFV PFEIFFER VACUUM TECHNOLOGY AG
HM B H&M HENNES & MAURITZ AB CLASS B
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
WAF SILTRONIC AG
DIM SARTORIUS STEDIM BIOTECH SA
MELE MELEXIS NV
SMHN SUESS MICROTEC AG
VACN VAT GROUP AG
SAP SAP SE
XFAB X-FAB SILICON FOUNDRIES SE
ASML ASML HOLDING NV
STM STMICROELECTRONICS NV
BESI BE SEMICONDUCTOR INDUSTRIES N.V.
ALKAL KALRAY SA
JEN JENOPTIK AG
ENR SIEMENS ENERGY AG
ARM ARM HOLDINGS PLC
AMS AMS-OSRAM AG
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.